Table 6. Correlation Between ER and PR Status With Clinico-pathological Data.

	N	ER Expression				PR Expression
		%	p1	Score ± SD	p2	%	p1	Score ± SD	p2
Age (years)			0.296		0.614		0.707		0.537
≤ 55	31	29		1.06 ± 2.30		35.5		1.87 ± 3.05
>55	26	42.3		1.38 ± 2.45		30.8		1.38 ± 2.80
FIGO Stage			0.568		0.105		0.170		0.045
I-II	20	40		1.90 ± 3.38		45		2.70 ± 3.68
III-IV	37	32.4		0.84 ± 1.48		27		1.08 ± 2.27
Residual disease			0.945		0.289		0.039		0.013
None/Optimal	31	35.5		1.52 ± 2.89		45.2		2.52 ± 3.45
Sub-optimal	26	34.6		0.85 ± 1.46		19.2		0.62 ± 1.67
Histologic type			0.813		0.570		0.088		0.010
Serous	24	33.3		1.00 ± 1.64		20.8		0.50 ± 1.06
No Serous	33	36.4		1.36 ± 2.78		42.4		2.48 ± 3.52
Histologic Grade			0.021		0.021		0.036		0.036
I-II	34	47.1		1.47 ± 0.50		44.1		1.44 ± 0.50
III	23	17.4		1.17 ± 0.38		17.4		1.17 ± 0.38
Ascites			0.599		0.986		0.84		0.933
<100 ml	23	39.1		1.22 ± 1.70		34.8		1.61 ± 2.72
>100 ml	34	32.4		1.21 ± 2.73		32.4		1.68 ± 3.09
Cytology			0.70		0.90		0.134		0.182
Negative	28	71.4		1.75 ± 3.02		42.9		2.18 ± 3.19
Positive	29	75.9		0.69 ± 1.31		24.1		1.14 ± 2.58

p¹: Chi-Square test; p²: Student test; %: positivity percentage; ER: Estrogen receptor; PR: Progesterone receptor; SD: standard deviation.